Browse by People

Collapse authors list.
Corrie, PG, Marshall, A, Nathan, PD, Lorigan, P, Gore, M, Tahir, S, Faust, G, Kelly, CG, Marples, M, Danson, SJ et al (show 28 more authors) , Marshall, E, Houston, SJ, Board, RE, Waterston, AM, Nobes, JP, Harries, M, Kumar, S, Goodman, A, Dalgleish, A, Martin-Clavijo, A, Westwell, S, Casasola, R, Chao, D, Maraveyas, A, Patel, PM, Ottensmeier, CH ORCID: 0000-0003-3619-1657, Farrugia, D, Humphreys, A, Eccles, B, Young, G, Barker, EO, Harman, C, Weiss, M, Myers, KA, Chhabra, A, Rodwell, SH, Dunn, JA and Middleton, MR (2019) Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial (vol 29, pg 1843, 2018). ANNALS OF ONCOLOGY, 30 (12). pp. 2013-2014.

Collapse authors list.
Fotopoulou, C, Vergote, I, Mainwaring, P, Bidzinski, M, Vermorken, JB, Ghamande, SA, Harnett, P, Del Prete, SA, Green, JA, Spaczynski, M et al (show 5 more authors) , Blagden, S, Gore, M, Ledermann, J, Kaye, S and Gabra, H (2014) Weekly AUC2 carboplatin is inactive in acquired platinum resistant ovarian cancer with or without phenoxodiol, a sensitiser of platinum cytotoxicity: the phase III OVATURE multicenter randomized study. Lancet Oncology, 25 (1). pp. 160-165.